Durene Elem Vaughn, DPM
Primary Podiatric Medicine · Lincoln Park, MINPI 1417904376
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Progenacare Global, LLC accounts for 73.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $1,979 and has fallen 90.0% since, to $197 in 2025.
Across 86 payments — averaging $32.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Progenacare Global, LLC$2K
- Convatec Inc.$362
- Kerecis Limited$133
- Nevro Corp.$105
- Mimedx Group, Inc.$39
- AbbVie$26
- plus $76 from 4 others
What the payments were for
- Travel & lodging$823%
- Food & beverage$2,72297%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Progenacare Global, LLC | 61 | $2,062 |
| Convatec Inc. | 13 | $362 |
| Kerecis Limited | 3 | $133 |
| Nevro Corp. | 2 | $105 |
| Mimedx Group, Inc. | 2 | $39 |
| AbbVie | 1 | $26 |
| Surgenex LLC | 1 | $26 |
| KCI USA, Inc. | 1 | $20 |
| Next Science LLC | 1 | $20 |
| Cardiovascular Systems Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$148
How this compares
$2,804 in reported general payments places this provider in the 80th percentile of 24 primary podiatric medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 241 | $5,130 |
| Ketoconazole | 97 | $4,006 |
| Ciclopirox | 182 | $3,762 |
| Ammonium Lactate | 178 | $3,718 |
| Triamcinolone Acetonide | 109 | $1,159 |
| Pregabalin | 15 | $771 |
| Gabapentin | 38 | $410 |
| Clotrimazole | 15 | $214 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $115 |
| Cephalexin | 15 | $64 |
| Meloxicam | 14 | $15 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Lincoln Park
- Thomas HoseyClinton Township$421K
- Manisha MehtaDetroit$10K
- Jessica PattersonAlpena$5K
- Kanika KochharAnn Arbor$4K
- Alan BlochNorthville$2K
- Lorne ZielaskowskiAlpena$1K
- Khalil Abu-JubaraClinton Township$1K
- Brandon WestWalled Lake$1K
- Jill ShinkBay City$960
- Shweta SaxenaPontiac$926
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.